A First In Human Study Of PF-00184562 In Healthy Volunteers

NCT00150215 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: PF-00184562
DRUG: Olanzapine

Sponsor

Pfizer

Collaborators

[object Object]